Trademark Overview
On Tuesday, October 14, 2025, a trademark application was filed for KEY2BRAIN with the United States Patent and Trademark Office. The USPTO has given the KEY2BRAIN trademark a serial number of 79437432. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Wednesday, March 11, 2026. This trademark is owned by Key2Brain AB. The KEY2BRAIN trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of central nervous system [cns] diseases; pharmaceutical preparations for the treatment of diseases caused by bacteria; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceuticals; chemical reagents for medical or veterinary purposes; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders.
Technological research; technological services and research relating thereto; design and development of medical technology; science and technology services; technological analysis services; consultancy relating to biotechnology; research and development in the field of biotechnology; information on the subject of scientific research in the field of biochemistry and biotechnology; research relating to molecular sciences; analysis in the field of molecular biology; drug discovery services; research on the subject of pharmaceuticals; pharmaceutical drug development services; research and development for the pharmaceutical industry; consultancy relating to pharmaceutical research and development; technical research in the field of pharmaceutical studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.
Chemical substances for use in the production of drugs; biological preparations for use in industry and science; biological preparations for use in science.
